Early Toxicity Assessment of Pelvic Volumetric Modulated Arc Therapy (VMAT) With Hypofractionated Simultaneous Integrated Boost to Prostate for High-Risk Prostate Cancer

被引：0
|
作者：
Ferrer, F. [1 ]
Boladeras, A. [1 ]
Pineiro, R. [1 ]
De Blas, R. [1 ]
Nunez, M. [1 ]
Del Carpio, A. [1 ]
Bejar, S. [1 ]
Zardoya, E. [1 ]
Picon, C. [1 ]
Gueda, F. [1 ]
机构：
[1] Inst Catala Oncol, Lhospitalet Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.1017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S388 / S388
页数：1
相关论文
共 50 条
  • [21] Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity
    Alongi, F.
    Fogliata, A.
    Navarria, P.
    Tozzi, A.
    Mancosu, P.
    Lobefalo, F.
    Reggiori, G.
    Clivio, A.
    Cozzi, L.
    Scorsetti, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (11) : 990 - 996
  • [22] Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer
    Dankulchai, Pittaya
    Sittiwong, Wiwatchai
    Teerasamit, Wanwarang
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (02) : 260 - 267
  • [23] Early Experience of Simultaneous Integrated Boost IMRT to the Prostate and Pelvic Nodes for High Risk Prostate Cancer
    Anand, G.
    Dunn, P.
    Moorfoot, P.
    Jones, E.
    Davies, G.
    Taylor, A.
    Falconer, A.
    Mangar, S.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 245 - 245
  • [24] Dosimetric evaluation of volumetric modulated arc therapy with simultaneous integrated boost hypofractionated radiation based on two types of multileaf collimators for prostate cancer
    Hassan, B. Z.
    Fathy, M. M.
    El-Gebaly, R. H.
    Mokhtar, M. H.
    ARAB JOURNAL OF NUCLEAR SCIENCES AND APPLICATIONS, 2022, 55 (01): : 77 - 84
  • [25] Hypofractionated simultaneous integrated boost with pelvic nodal irradiation for prostate cancer
    Lekshmi, R.
    Joseph, Deepa M.
    Namitha, R. S.
    Kaur, Harpreet
    Gupta, Sweety
    Gupta, Manoj
    RADIOTHERAPY AND ONCOLOGY, 2024, 197 : S282 - S284
  • [26] VOLUMETRIC MODULATED ARC THERAPY(VMAT) FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER
    Shiraishi, Kenshiro
    Yamamoto, Kentaro
    Haga, Akihiro
    Sakumi, Akira
    Nomoto, Akihiro
    Nakagawa, Keiichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [27] Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases
    Cilia, Savino
    Deodato, Francesco
    Digesu, Cinzia
    Macchia, Gabriella
    Picardi, Vincenzo
    Ferro, Marica
    Sallustio, Giuseppina
    De Spirito, Marco
    Piermattei, Angelo
    Morganti, Alessio G.
    MEDICAL DOSIMETRY, 2014, 39 (01) : 108 - 116
  • [28] Single Arc Volumetric Modulated Arc Therapy (VMAT) for the Treatment of Prostate and Pelvic Lymph Nodes
    Wai, P.
    Sardo, A.
    Bedford, J. L.
    Warrington, A. P.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 256 - 256
  • [29] HYPOFRACTIONATED CONCOMITANT INTENSITY-MODULATED RADIOTHERAPY BOOST FOR HIGH-RISK PROSTATE CANCER: LATE TOXICITY
    Quon, Harvey
    Cheung, Patrick C. F.
    Loblaw, D. Andrew
    Morton, Gerard
    Pang, Geordi
    Szumacher, Ewa
    Danjoux, Cyril
    Choo, Richard
    Thomas, Gillian
    Kiss, Alex
    Mamedov, Alexandre
    Deabreu, Andrea
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 898 - 905
  • [30] Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control
    Saracino, Biancamaria
    Petrongari, Maria Grazia
    Marzi, Simona
    Bruzzaniti, Vicente
    Sara, Gomellini
    Arcangeli, Stefano
    Arcangeli, Giorgio
    Pinnaro, Paola
    Giordano, Carolina
    Ferraro, Anna Maria
    Strigari, Lidia
    CANCER MEDICINE, 2014, 3 (05): : 1313 - 1321
12345